Active

Foresite Capital

Investor type

VC

Founded

2011

AUM

$3 500 M

Location

San Francisco, California, United States

Investment Ticket

$0-1 m

Investment Stage

Seed Series B Series A

Region of investment

North America Europe
Investor profile last updated: 23 April, 2025

Profile

The biggest healthcare problems won’t be solved by a typical approach.

We focus
On therapeutics, devices, diagnostics and services, and we use data science to drive much of our decision making.

We invest
In people, ideas and discoveries that could save lives and transform healthcare, and we are intrigued by the intersection between biology and big data.

FULL LIFECYCLE INVESTING

We partner at all stages – from incubation to IPO and beyond. Our goal is to have impact regardless of timing.

DEEP COLLABORATION

Our team of investment analysts, MD/PhDs and data scientists work closely with each company we invest in.

INDUSTRY KNOW-HOW

We have extensive operational and investment experience to guide our decisions and offer guidance.

EXTENSIVE NETWORKS

We have friends, partners and former colleagues throughout the healthcare ecosystem, and we consult them to help visionaries realize their dreams.

We provide complete capital solutions at all stages to help build the next category-defining companies, because value creation goes beyond the IPO.

Industry

Fashion/Beauty Healthcare Services Other Software HealthTech Medical Devices Transportation MedTech Technology Life Sciences Infrastructure Biotechnology Food and Beverage Foodtech

Foresite Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Foresite Capital Fund III, L.P
Venture Capital (VC)
Healthcare Services
Life Sciences
Seed
Series A
Series B
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
$5-10 m
$450 M
July 2015
Foresite Capital Fund IV, L.P
Venture Capital (VC)
Healthcare Services
Life Sciences
Seed
Series A
Series B
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
$5-10 m
$668 M
May 2018
Foresite Capital Opportunity Fund V, L.P.
Venture Capital (VC)
Healthcare Services
Life Sciences
Seed
Series A
Series B
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
$5-10 m
$186 M
February 2021
Foresite Capital Fund VI, L.P
Venture Capital (VC)
Healthcare Services
Life Sciences
Seed
Series A
Series B
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
$5-10 m
$900 M
June 2024
Foresite Labs Fund
Fund of funds
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Infrastructure
Seed
Series A
Series B
North America
$5-10 m
$173 M
March 2022
Foresite Capital Fund V, L.P
Fund of funds
Food and Beverage
Foodtech
Technology
Life Sciences
Infrastructure
HealthTech
Seed
Series A
Series B
North America
$5-10 m
$783 M
February 2021

Contacts

Name
Title
Email
avatar
Noah Dennis Product Manager, Investment Analytics
Product Manager, Investment Analytics
d•••@•••
avatar
Vik Bajaj Managing Director
Managing Director
v•••@•••
Upgrade to see contacts
avatar
OTAj1Z50gl9vPVrX OTAj1Z50gl9vPVrX
OTAj1Z50gl9vPVrX
avatar
OTAj1Z50gl9vPVrX OTAj1Z50gl9vPVrX
OTAj1Z50gl9vPVrX
avatar
OTAj1Z50gl9vPVrX OTAj1Z50gl9vPVrX
OTAj1Z50gl9vPVrX
Investment-team contacts for Foresite Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Foresite Capital

Foresite Capital is a venture capital firm. It backs companies at Seed, Series B and Series A, writing tickets of $0-1 m.
Foresite Capital is located in San Francisco, California, United States.
Foresite Capital was founded in 2011.
Foresite Capital invests in companies and startups in Fashion/Beauty, Healthcare Services, Other, Software, HealthTech, Medical Devices, Transportation, MedTech, Technology, Life Sciences, Infrastructure, Biotechnology, Food and Beverage, Foodtech.
Foresite Capital invests in companies and startups in North America, Europe.
Foresite Capital invests in companies and startups at Seed, Series B, Series A.
Foresite Capital usually invests $0-1 m on average.
Foresite Capital has around $3 500m assets under management.
Foresite Capital last fund was created/launched in 2024-06-12
Foresite Capital can be reached through its website foresitecapital.com, its LinkedIn page and its X account. Its general enquiries address is info@foresitecapital.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Foresite Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Foresite Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 23 April, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.